{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T02:45:32Z","timestamp":1792032332977,"version":"4.4.0"},"reference-count":140,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82430110"],"award-info":[{"award-number":["82430110"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473790"],"award-info":[{"award-number":["82473790"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Jiangsu Province Natural Science Foundation","award":["BK20253030"],"award-info":[{"award-number":["BK20253030"]}]},{"name":"Jiangsu Province Natural Science Foundation","award":["BK20250201"],"award-info":[{"award-number":["BK20250201"]}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Enzyme Inhibition and Medicinal Chemistry"],"published-print":{"date-parts":[[2026,12,31]]},"DOI":"10.1080\/14756366.2026.2744392","type":"journal-article","created":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T02:07:07Z","timestamp":1792030027000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Research progress on ATP-citrate lyase and its inhibitors: a metabolic-epigenetic perspective"],"prefix":"10.1080","volume":"41","author":[{"given":"Qinglin","family":"Liu","sequence":"first","affiliation":[{"name":"Jiangsu Key Laboratory of Drug Discovery for Metabolic Disease, State Key Laboratory of Natural Medicines, China Pharmaceutical University","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbin","family":"Sun","sequence":"additional","affiliation":[{"name":"Jiangsu Key Laboratory of Drug Discovery for Metabolic Disease, State Key Laboratory of Natural Medicines, China Pharmaceutical University","place":["Nanjing, China"]},{"name":"Chongqing Innovation Institute of China Pharmaceutical University","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Dai","sequence":"additional","affiliation":[{"name":"Jiangsu Key Laboratory of Drug Discovery for Metabolic Disease, State Key Laboratory of Natural Medicines, China Pharmaceutical University","place":["Nanjing, China"]},{"name":"Chongqing Innovation Institute of China Pharmaceutical University","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,10,14]]},"reference":[{"issue":"10","key":"e_1_3_3_2_1","doi-asserted-by":"crossref","first-page":"7011","DOI":"10.1074\/jbc.M114.551051","article-title":"Glucose-dependent de novo lipogenesis in B lymphocytes: a requirement for atp-citrate lyase in lipopolysaccharide-induced differentiation","volume":"289","author":"Dufort FJ","year":"2014","unstructured":"Dufort FJ, Gumina MR, Ta NL, Tao Y, Heyse SA, Scott DA, Richardson AD, Seyfried TN, Chiles TC. Glucose-dependent de novo lipogenesis in B lymphocytes: a requirement for atp-citrate lyase in lipopolysaccharide-induced differentiation. J Biol Chem. 2014;289(10):7011\u20137024.","journal-title":"J Biol Chem"},{"issue":"1","key":"e_1_3_3_3_1","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41594-019-0351-6","article-title":"Molecular basis for acetyl-CoA production by ATP-citrate lyase","volume":"27","author":"Wei X","year":"2020","unstructured":"Wei X, Schultz K, Bazilevsky GA, Vogt A, Marmorstein R. Molecular basis for acetyl-CoA production by ATP-citrate lyase. Nat Struct Mol Biol. 2020;27(1):33\u201341.","journal-title":"Nat Struct Mol Biol"},{"issue":"1","key":"e_1_3_3_4_1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cmet.2025.12.005","article-title":"Acetyl-CoA-producing enzymes are a targetable metabolic entry point to MASLD and liver fibrosis","volume":"38","author":"Lurje I","year":"2026","unstructured":"Lurje I, Tacke F. Acetyl-CoA-producing enzymes are a targetable metabolic entry point to MASLD and liver fibrosis. Cell Metab. 2026;38(1):9\u201311.","journal-title":"Cell Metab"},{"issue":"1","key":"e_1_3_3_5_1","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.cmet.2024.10.013","article-title":"A hierarchical hepatic de novo lipogenesis substrate supply network utilizing pyruvate, acetate, and ketones","volume":"37","author":"Rauckhorst AJ","year":"2025","unstructured":"Rauckhorst AJ, Sheldon RD, Pape DJ, Ahmed A, Falls-Hubert KC, Merrill RA, Brown RF, Deshmukh K, Vallim TA, Deja S, et al. A hierarchical hepatic de novo lipogenesis substrate supply network utilizing pyruvate, acetate, and ketones. Cell Metab. 2025;37(1):255\u2013273.e6.","journal-title":"Cell Metab"},{"issue":"31","key":"e_1_3_3_6_1","doi-asserted-by":"crossref","first-page":"e14367","DOI":"10.1002\/advs.202414367","article-title":"The nuclear localization of ACLY guards early embryo development through recruiting P300 and HAT1 to promote histone acetylation and transcription","volume":"12","author":"Ma Y","year":"2025","unstructured":"Ma Y, Zhang Y, Yang W, Tong X, Liu S, Zhou Y, Qiu M, Jiang H, Hu Z, Ren P, et al. The nuclear localization of ACLY guards early embryo development through recruiting P300 and HAT1 to promote histone acetylation and transcription. Adv Sci (Weinh). 2025;12(31):e14367.","journal-title":"Adv Sci (Weinh)"},{"issue":"5930","key":"e_1_3_3_7_1","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1126\/science.1164097","article-title":"ATP-citrate lyase links cellular metabolism to histone acetylation","volume":"324","author":"Wellen KE","year":"2009","unstructured":"Wellen KE, Hatzivassiliou G, Sachdeva UM, Bui TV, Cross JR, Thompson CB. ATP-citrate lyase links cellular metabolism to histone acetylation. Science. 2009;324(5930):1076\u20131080.","journal-title":"Science"},{"issue":"1","key":"e_1_3_3_8_1","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.tibs.2017.11.004","article-title":"Spatiotemporal control of acetyl-CoA metabolism in chromatin regulation","volume":"43","author":"Sivanand S","year":"2018","unstructured":"Sivanand S, Viney I, Wellen KE. Spatiotemporal control of acetyl-CoA metabolism in chromatin regulation. Trends Biochem Sci. 2018;43(1):61\u201374.","journal-title":"Trends Biochem Sci"},{"key":"e_1_3_3_9_1","doi-asserted-by":"crossref","first-page":"1663958","DOI":"10.3389\/fendo.2025.1663958","article-title":"ACLY facilitates alanine flux in the livers of db\/db mice: a hyperpolarized [1-13C]pyruvate MRS study","volume":"16","author":"Choi YS","year":"2025","unstructured":"Choi YS, Song JE, Lim SH, Song HT. ACLY facilitates alanine flux in the livers of db\/db mice: a hyperpolarized [1-13C]pyruvate MRS study. Front Endocrinol (Lausanne). 2025;16:1663958.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"e_1_3_3_10_1","first-page":"601","article-title":"ATP citrate lyase (ACLY)-dependent immunometabolism in mucosal T cells drives experimental colitis in vivo","volume":"73","author":"Schulz-Kuhnt A","year":"2024","unstructured":"Schulz-Kuhnt A, R\u00fchle K, Javidmehr A, D\u00f6br\u00f6nti M, Biwank J, Knittel S, Neidlinger P, Leupold J, Liu L-J, Dedden M, et al. ATP citrate lyase (ACLY)-dependent immunometabolism in mucosal T cells drives experimental colitis in vivo. Gut. 2024;73(4):601\u2013612.","journal-title":"Gut"},{"issue":"2","key":"e_1_3_3_11_1","doi-asserted-by":"crossref","first-page":"100069","DOI":"10.1016\/j.bneo.2025.100069","article-title":"A feedforward loop between ACLY and MYC supports T-ALL progression in vivo","volume":"2","author":"da Silva-Diz V","year":"2025","unstructured":"da Silva-Diz V, Singh A, Aleksandrova M, Kim O, Thai C, Lancho O, Renck Nunes P, Affronti H, Mart\u00ednez de Paz A, Josefowicz SZ, et al. A feedforward loop between ACLY and MYC supports T-ALL progression in vivo. Blood Neoplasia. 2025;2(2):100069.","journal-title":"Blood Neoplasia"},{"issue":"11","key":"e_1_3_3_12_1","doi-asserted-by":"crossref","first-page":"e70919","DOI":"10.1002\/alz.70919","article-title":"ACLY regulates autolysosome acidification through tubulin acetylation-mediated assembly of V-ATPase subunits in Alzheimer\u2019s disease model mice","volume":"21","author":"Lin A","year":"2025","unstructured":"Lin A, Dai X, Chen J, Han T, Du Q, Wu M, Cheng J, Chen W, Ye Q, Chen X, et al. ACLY regulates autolysosome acidification through tubulin acetylation-mediated assembly of V-ATPase subunits in Alzheimer\u2019s disease model mice. Alzheimers Dement. 2025;21(11):e70919.","journal-title":"Alzheimers Dement"},{"issue":"9","key":"e_1_3_3_13_1","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1016\/j.celrep.2019.04.112","article-title":"Adipocyte ACLY facilitates dietary carbohydrate handling to maintain metabolic homeostasis in females","volume":"27","author":"Fernandez S","year":"2019","unstructured":"Fernandez S, Viola JM, Torres A, Wallace M, Trefely S, Zhao S, Affronti HC, Gengatharan JM, Guertin DA, Snyder NW, et al. Adipocyte ACLY facilitates dietary carbohydrate handling to maintain metabolic homeostasis in females. Cell Rep. 2019;27(9):2772\u20132784.e6.","journal-title":"Cell Rep"},{"issue":"1","key":"e_1_3_3_14_1","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1186\/s12967-023-04431-w","article-title":"ACLY as a modulator of liver cell functions and its role in metabolic dysfunction-associated steatohepatitis","volume":"21","author":"Convertini P","year":"2023","unstructured":"Convertini P, Santarsiero A, Todisco S, Gilio M, Palazzo D, Pappalardo I, Iacobazzi D, Frontuto M, Infantino V. ACLY as a modulator of liver cell functions and its role in metabolic dysfunction-associated steatohepatitis. J Transl Med. 2023;21(1):568.","journal-title":"J Transl Med"},{"issue":"42","key":"e_1_3_3_15_1","doi-asserted-by":"crossref","first-page":"e2402674121","DOI":"10.1073\/pnas.2402674121","article-title":"O-GlcNAcylation of ATP-citrate lyase couples glucose supply to lipogenesis for rapid tumor cell proliferation","volume":"121","author":"Liu J","year":"2024","unstructured":"Liu J, Wang Y, Tian M, Xia M, Zheng Y, Hao M, Qian Y, Shu H, Zhang W, Peng P, et al. O-GlcNAcylation of ATP-citrate lyase couples glucose supply to lipogenesis for rapid tumor cell proliferation. Proc Natl Acad Sci U S A. 2024;121(42):e2402674121.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"e_1_3_3_16_1","doi-asserted-by":"crossref","first-page":"e2213272120","DOI":"10.1073\/pnas.2213272120","article-title":"Cytoskeletal association of ATP citrate lyase controls the mechanodynamics of macropinocytosis","volume":"120","author":"Puccini J","year":"2023","unstructured":"Puccini J, Wei J, Tong L, Bar-Sagi D. Cytoskeletal association of ATP citrate lyase controls the mechanodynamics of macropinocytosis. Proc Natl Acad Sci U S A. 2023;120(8):e2213272120.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"e_1_3_3_17_1","doi-asserted-by":"crossref","first-page":"e20231332","DOI":"10.1084\/jem.20231820","article-title":"ACLY and ACSS2\u2009link nutrient-dependent chromatin accessibility to CD8 T cell effector responses","volume":"221","author":"Kaymak I","year":"2024","unstructured":"Kaymak I, Watson MJ, Oswald BM, Ma S, Johnson BK, DeCamp LM, Mabvakure BM, Luda KM, Ma EH, Lau K, et al. ACLY and ACSS2\u2009link nutrient-dependent chromatin accessibility to CD8 T cell effector responses. J Exp Med. 2024;221(9):e20231332.","journal-title":"J Exp Med"},{"issue":"12","key":"e_1_3_3_18_1","doi-asserted-by":"crossref","first-page":"115015","DOI":"10.1016\/j.celrep.2024.115015","article-title":"Nucleo-cytosolic acetyl-CoA drives tumor immune evasion by regulating PD-L1 in melanoma","volume":"43","author":"Wang H","year":"2024","unstructured":"Wang H, Yi X, Wang X, Yang Y, Zhang H, Wang H, Chen J, Zhang B, Guo S, Wu L, et al. Nucleo-cytosolic acetyl-CoA drives tumor immune evasion by regulating PD-L1 in melanoma. Cell Rep. 2024;43(12):115015.","journal-title":"Cell Rep"},{"key":"e_1_3_3_19_1","doi-asserted-by":"crossref","first-page":"101314","DOI":"10.1016\/j.neo.2026.101314","article-title":"Metabolic regulation of histone acetylation by ACLY supports MDR1 expression in colorectal cancer and highlights a targetable vulnerability","volume":"77","author":"Garc\u00eda-Bautista A","year":"2026","unstructured":"Garc\u00eda-Bautista A, Cenigaonandia-Campillo A, Rio-Vilari\u00f1o A, Sanz-Criado L, Selva-Gim\u00e9nez M, Perez-Antol\u00edn R, Cebri\u00e1n A, Garc\u00eda-Garc\u00eda L, Fern\u00e1ndez-Ace\u00f1ero MJ, Ba\u00f1os-Herraiz N, et al. Metabolic regulation of histone acetylation by ACLY supports MDR1 expression in colorectal cancer and highlights a targetable vulnerability. Neoplasia. 2026;77:101314.","journal-title":"Neoplasia"},{"issue":"11","key":"e_1_3_3_20_1","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.3390\/cells10112962","article-title":"ACLY nuclear translocation in human macrophages drives proinflammatory gene expression by NF-\u03baB acetylation","volume":"10","author":"Santarsiero A","year":"2021","unstructured":"Santarsiero A, Convertini P, Todisco S, Pierri CL, De Grassi A, Williams NC, Iacobazzi D, De Stefano G, O\u2019Neill LAJ, Infantino V, et al. ACLY nuclear translocation in human macrophages drives proinflammatory gene expression by NF-\u03baB acetylation. Cells. 2021;10(11):2962.","journal-title":"Cells"},{"issue":"6","key":"e_1_3_3_21_1","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1038\/s44318-025-00369-5","article-title":"SLC25A1 and ACLY maintain cytosolic acetyl-CoA and regulate ferroptosis susceptibility via FSP1 acetylation","volume":"44","author":"Li W","year":"2025","unstructured":"Li W, Han J, Huang B, Xu T, Wan Y, Luo D, Kong W, Yu Y, Zhang L, Nian Y, et al. SLC25A1 and ACLY maintain cytosolic acetyl-CoA and regulate ferroptosis susceptibility via FSP1 acetylation. Embo J. 2025;44(6):1641\u20131662.","journal-title":"Embo J"},{"key":"e_1_3_3_22_1","doi-asserted-by":"crossref","first-page":"106933","DOI":"10.1016\/j.bioorg.2023.106933","article-title":"Recent advance of ATP citrate lyase inhibitors for the treatment of cancer and related diseases","volume":"142","author":"Liang J-J","year":"2024","unstructured":"Liang J-J, Zhou X-F, Long H, Li C-Y, Wei J, Yu X-Q, Guo Z-Y, Zhou Y-Q, Deng Z-S. Recent advance of ATP citrate lyase inhibitors for the treatment of cancer and related diseases. Bioorg Chem. 2024;142:106933.","journal-title":"Bioorg Chem"},{"key":"e_1_3_3_23_1","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.ejmech.2018.09.001","article-title":"ATP citrate lyase (ACLY) inhibitors: an anti-cancer strategy at the crossroads of glucose and lipid metabolism","volume":"157","author":"Granchi C.","year":"2018","unstructured":"Granchi C. ATP citrate lyase (ACLY) inhibitors: an anti-cancer strategy at the crossroads of glucose and lipid metabolism. Eur J Med Chem. 2018;157:1276\u20131291.","journal-title":"Eur J Med Chem"},{"key":"e_1_3_3_24_1","doi-asserted-by":"crossref","first-page":"108348","DOI":"10.1016\/j.phrs.2026.108348","article-title":"Targeting ATP-citrate lyase across cardiometabolic and oncologic disease","volume":"231","author":"Macchi C","year":"2026","unstructured":"Macchi C, Pedretti S, Ghisletti S, Corsini A, Mitro N, Sirtori CR, Ruscica M. Targeting ATP-citrate lyase across cardiometabolic and oncologic disease. Pharmacol Res. 2026;231:108348.","journal-title":"Pharmacol Res"},{"key":"e_1_3_3_25_1","doi-asserted-by":"crossref","first-page":"108346","DOI":"10.1016\/j.phrs.2026.108346","article-title":"Acetyl-CoA metabolism in skeletal biology and bone disorders: From mechanisms to therapeutic implications","volume":"231","author":"Yang Q","year":"2026","unstructured":"Yang Q, Shi R, Zhang C, Sun W, Chen G. Acetyl-CoA metabolism in skeletal biology and bone disorders: From mechanisms to therapeutic implications. Pharmacol Res. 2026;231:108346.","journal-title":"Pharmacol Res"},{"issue":"1","key":"e_1_3_3_26_1","doi-asserted-by":"crossref","first-page":"2689852","DOI":"10.1080\/14756366.2026.2689852","article-title":"New insights into the ACLY-mediated metabolic and epigenetic interplay in macrophages","volume":"41","author":"Yuan L","year":"2026","unstructured":"Yuan L, Wang T, Song Y, Guo P, Zhu Y, Cao Y, Song B, Yu Z. New insights into the ACLY-mediated metabolic and epigenetic interplay in macrophages. J Enzyme Inhib Med Chem. 2026;41(1):2689852.","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"3","key":"e_1_3_3_27_1","doi-asserted-by":"crossref","first-page":"208","DOI":"10.53365\/nrfhh\/189500","article-title":"ATP-citrate lyase (ACLY): an extensive investigation from molecular insight to therapeutic implications","volume":"4","author":"Biju AK","year":"2024","unstructured":"Biju AK, Chennam Lakshmikumar RR, Rengasamy KR. ATP-citrate lyase (ACLY): an extensive investigation from molecular insight to therapeutic implications. NRFHH. 2024;4(3):208\u2013229.","journal-title":"NRFHH"},{"issue":"7","key":"e_1_3_3_28_1","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/s44161-024-00502-3","article-title":"Nuclear ATP-citrate lyase regulates chromatin-dependent activation and maintenance of the myofibroblast gene program","volume":"3","author":"Lazaropoulos MP","year":"2024","unstructured":"Lazaropoulos MP, Gibb AA, Chapski DJ, Nair AA, Reiter AN, Roy R, Eaton DM, Bedi KC, Margulies KB, Wellen KE, et al. Nuclear ATP-citrate lyase regulates chromatin-dependent activation and maintenance of the myofibroblast gene program. Nat Cardiovasc Res. 2024;3(7):869\u2013882.","journal-title":"Nat Cardiovasc Res"},{"issue":"2","key":"e_1_3_3_29_1","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1432-1033.1992.tb16659.x","article-title":"Cloning and expression of a human ATP-citrate lyase cDNA","volume":"204","author":"Elshourbagy NA","year":"1992","unstructured":"Elshourbagy NA, Near JC, Kmetz PJ, Wells TN, Groot PH, Saxty BA, Hughes SA, Franklin M, Gloger IS. Cloning and expression of a human ATP-citrate lyase cDNA. Eur J Biochem. 1992;204(2):491\u2013499.","journal-title":"Eur J Biochem"},{"issue":"7753","key":"e_1_3_3_30_1","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/s41586-019-1094-6","article-title":"An allosteric mechanism for potent inhibition of human ATP-citrate lyase","volume":"568","author":"Wei J","year":"2019","unstructured":"Wei J, Leit S, Kuai J, Therrien E, Rafi S, Harwood HJ, DeLaBarre B, Tong L. An allosteric mechanism for potent inhibition of human ATP-citrate lyase. Nature. 2019;568(7753):566\u2013570.","journal-title":"Nature"},{"issue":"7753","key":"e_1_3_3_31_1","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/s41586-019-1095-5","article-title":"Structure of ATP citrate lyase and the origin of citrate synthase in the Krebs cycle","volume":"568","author":"Verschueren KHG","year":"2019","unstructured":"Verschueren KHG, Blanchet C, Felix J, Dansercoer A, De Vos D, Bloch Y, Van Beeumen J, Svergun D, Gutsche I, Savvides SN, et al. Structure of ATP citrate lyase and the origin of citrate synthase in the Krebs cycle. Nature. 2019;568(7753):571\u2013575.","journal-title":"Nature"},{"issue":"1","key":"e_1_3_3_32_1","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1038\/s41467-023-37986-9","article-title":"Allosteric role of the citrate synthase homology domain of ATP citrate lyase","volume":"14","author":"Wei X","year":"2023","unstructured":"Wei X, Schultz K, Pepper HL, Megill E, Vogt A, Snyder NW, Marmorstein R. Allosteric role of the citrate synthase homology domain of ATP citrate lyase. Nat Commun. 2023;14(1):2247.","journal-title":"Nat Commun"},{"issue":"3","key":"e_1_3_3_33_1","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/s41568-022-00543-5","article-title":"Acetyl-CoA metabolism in cancer","volume":"23","author":"Guertin DA","year":"2023","unstructured":"Guertin DA, Wellen KE. Acetyl-CoA metabolism in cancer. Nat Rev Cancer. 2023;23(3):156\u2013172.","journal-title":"Nat Rev Cancer"},{"issue":"25","key":"e_1_3_3_34_1","doi-asserted-by":"crossref","first-page":"5198","DOI":"10.1021\/bi300611s","article-title":"On the catalytic mechanism of human ATP citrate lyase","volume":"51","author":"Fan F","year":"2012","unstructured":"Fan F, Williams HJ, Boyer JG, Graham TL, Zhao H, Lehr R, Qi H, Schwartz B, Raushel FM, Meek TD, et al. On the catalytic mechanism of human ATP citrate lyase. Biochemistry. 2012;51(25):5198\u20135211.","journal-title":"Biochemistry"},{"issue":"18","key":"e_1_3_3_35_1","doi-asserted-by":"crossref","first-page":"7259","DOI":"10.1074\/jbc.RA118.006685","article-title":"ATP-citrate lyase multimerization is required for coenzyme-A substrate binding and catalysis","volume":"294","author":"Bazilevsky GA","year":"2019","unstructured":"Bazilevsky GA, Affronti HC, Wei X, Campbell SL, Wellen KE, Marmorstein R. ATP-citrate lyase multimerization is required for coenzyme-A substrate binding and catalysis. J Biol Chem. 2019;294(18):7259\u20137268.","journal-title":"J Biol Chem"},{"issue":"8","key":"e_1_3_3_36_1","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/s41594-021-00624-3","article-title":"Acetyl-CoA is produced by the citrate synthase homology module of ATP-citrate lyase","volume":"28","author":"Verstraete K","year":"2021","unstructured":"Verstraete K, Verschueren KHG, Dansercoer A, Savvides SN. Acetyl-CoA is produced by the citrate synthase homology module of ATP-citrate lyase. Nat Struct Mol Biol. 2021;28(8):636\u2013638.","journal-title":"Nat Struct Mol Biol"},{"issue":"5","key":"e_1_3_3_37_1","doi-asserted-by":"crossref","first-page":"112488","DOI":"10.1016\/j.celrep.2023.112488","article-title":"Acetyl-CoA carboxylase 1 is a suppressor of the adipocyte thermogenic program","volume":"42","author":"Guilherme A","year":"2023","unstructured":"Guilherme A, Rowland LA, Wetoska N, Tsagkaraki E, Santos KB, Bedard AH, Henriques F, Kelly M, Munroe S, Pedersen DJ, et al. Acetyl-CoA carboxylase 1 is a suppressor of the adipocyte thermogenic program. Cell Rep. 2023;42(5):112488.","journal-title":"Cell Rep"},{"issue":"6257","key":"e_1_3_3_38_1","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/343425a0","article-title":"Regulation of the mevalonate pathway","volume":"343","author":"Goldstein JL","year":"1990","unstructured":"Goldstein JL, Brown MS. Regulation of the mevalonate pathway. Nature. 1990;343(6257):425\u2013430.","journal-title":"Nature"},{"key":"e_1_3_3_39_1","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.canlet.2019.12.010","article-title":"ATP citrate lyase: a central metabolic enzyme in cancer","volume":"471","author":"Icard P","year":"2020","unstructured":"Icard P, Wu Z, Fournel L, Coquerel A, Lincet H, Alifano M. ATP citrate lyase: a central metabolic enzyme in cancer. Cancer Lett. 2020;471:125\u2013134.","journal-title":"Cancer Lett"},{"issue":"1","key":"e_1_3_3_40_1","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1186\/s12915-025-02423-4","article-title":"TCA-cycle metabolites in the nucleus: drivers of chromatin and epigenetic control","volume":"23","author":"Ghisletti S","year":"2025","unstructured":"Ghisletti S, Russo M. TCA-cycle metabolites in the nucleus: drivers of chromatin and epigenetic control. BMC Biol. 2025;23(1):316.","journal-title":"BMC Biol"},{"issue":"2","key":"e_1_3_3_41_1","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.molcel.2017.06.008","article-title":"Nuclear acetyl-CoA production by ACLY promotes homologous recombination","volume":"67","author":"Sivanand S","year":"2017","unstructured":"Sivanand S, Rhoades S, Jiang Q, Lee JV, Benci J, Zhang J, Yuan S, Viney I, Zhao S, Carrer A, et al. Nuclear acetyl-CoA production by ACLY promotes homologous recombination. Mol Cell. 2017;67(2):252\u2013265.e6.","journal-title":"Mol Cell"},{"issue":"6","key":"e_1_3_3_42_1","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.immuni.2019.11.009","article-title":"Toll-like receptor signaling rewires macrophage metabolism and promotes histone acetylation via ATP-citrate lyase","volume":"51","author":"Lauterbach MA","year":"2019","unstructured":"Lauterbach MA, Hanke JE, Serefidou M, Mangan MSJ, Kolbe C-C, Hess T, Rothe M, Kaiser R, Hoss F, Gehlen J, et al. Toll-like receptor signaling rewires macrophage metabolism and promotes histone acetylation via ATP-citrate lyase. Immunity. 2019;51(6):997\u20131011.e7.","journal-title":"Immunity"},{"key":"e_1_3_3_43_1","doi-asserted-by":"crossref","first-page":"107706","DOI":"10.1016\/j.phrs.2025.107706","article-title":"Dual inhibition of hepatic ACLY and ACSS2: A synergistic approach to combat NAFLD through lipogenesis reduction and mitochondrial enhancement","volume":"215","author":"Zhang M","year":"2025","unstructured":"Zhang M, Ji J, Lei Y, Qin F, Tao Y, Li N, Bian J, Li Z, Lai M, Qiu Z, et al. Dual inhibition of hepatic ACLY and ACSS2: A synergistic approach to combat NAFLD through lipogenesis reduction and mitochondrial enhancement. Pharmacol Res. 2025;215:107706.","journal-title":"Pharmacol Res"},{"issue":"1","key":"e_1_3_3_44_1","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1021\/acsptsci.4c00476","article-title":"Molecular targets and small molecules modulating acetyl coenzyme A in physiology and diseases","volume":"8","author":"Ewida H","year":"2025","unstructured":"Ewida H, Benson H, Tareq S, Ahmed MS. Molecular targets and small molecules modulating acetyl coenzyme A in physiology and diseases. ACS Pharmacol Transl Sci. 2025;8(1):36\u201346.","journal-title":"ACS Pharmacol Transl Sci"},{"issue":"10","key":"e_1_3_3_45_1","doi-asserted-by":"crossref","first-page":"102401","DOI":"10.1016\/j.jbc.2022.102401","article-title":"Paradoxical activation of transcription factor SREBP1c and de novo lipogenesis by hepatocyte-selective ATP-citrate lyase depletion in obese mice","volume":"298","author":"Yenilmez B","year":"2022","unstructured":"Yenilmez B, Kelly M, Zhang G-F, Wetoska N, Ilkayeva OR, Min K, Rowland L, DiMarzio C, He W, Raymond N, et al. Paradoxical activation of transcription factor SREBP1c and de novo lipogenesis by hepatocyte-selective ATP-citrate lyase depletion in obese mice. J Biol Chem. 2022;298(10):102401.","journal-title":"J Biol Chem"},{"issue":"1","key":"e_1_3_3_46_1","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.cmet.2024.10.014","article-title":"Bempedoic acid suppresses diet-induced hepatic steatosis independently of ATP-citrate lyase","volume":"37","author":"Liu JY","year":"2025","unstructured":"Liu JY, Kuna RS, Pinheiro LV, Nguyen PTT, Welles JE, Drummond JM, Murali N, Sharma PV, Supplee JG, Shiue M, et al. Bempedoic acid suppresses diet-induced hepatic steatosis independently of ATP-citrate lyase. Cell Metab. 2025;37(1):239\u2013254.e7.","journal-title":"Cell Metab"},{"issue":"2","key":"e_1_3_3_47_1","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.jhep.2025.02.033","article-title":"Integrative metabolism in MASLD and MASH: Pathophysiology and emerging mechanisms","volume":"83","author":"Steinberg GR","year":"2025","unstructured":"Steinberg GR, Valvano CM, De Nardo W, Watt MJ. Integrative metabolism in MASLD and MASH: Pathophysiology and emerging mechanisms. J Hepatol. 2025;83(2):584\u2013595.","journal-title":"J Hepatol"},{"issue":"2","key":"e_1_3_3_48_1","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3390\/biom16020339","article-title":"Modulation and reprogramming of adipose tissue macrophages in obesity","volume":"16","author":"Liu Y","year":"2026","unstructured":"Liu Y, Huang X, Sang L, Zhang Y, Cao J, Kong Q. Modulation and reprogramming of adipose tissue macrophages in obesity. Biomolecules. 2026;16(2):339.","journal-title":"Biomolecules"},{"issue":"777","key":"e_1_3_3_49_1","doi-asserted-by":"crossref","first-page":"eado7824","DOI":"10.1126\/scitranslmed.ado7824","article-title":"ATP citrate lyase drives vascular remodeling in systemic and pulmonary vascular diseases through metabolic and epigenetic changes","volume":"16","author":"Grobs Y","year":"2024","unstructured":"Grobs Y, Romanet C, Lemay S-E, Bourgeois A, Voisine P, Theberge C, Sauvaget M, Breuils-Bonnet S, Martineau S, El Kabbout R, et al. ATP citrate lyase drives vascular remodeling in systemic and pulmonary vascular diseases through metabolic and epigenetic changes. Sci Transl Med. 2024;16(777):eado7824.","journal-title":"Sci Transl Med"},{"issue":"8080","key":"e_1_3_3_50_1","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/s41586-025-09297-0","article-title":"ACLY inhibition promotes tumour immunity and suppresses liver cancer","volume":"645","author":"Gautam J","year":"2025","unstructured":"Gautam J, Wu J, Lally JSV, McNicol JD, Fayyazi R, Ahmadi E, Oniciu DC, Heaton S, Newton RS, Rehal S, et al. ACLY inhibition promotes tumour immunity and suppresses liver cancer. Nature. 2025;645(8080):507\u2013517.","journal-title":"Nature"},{"issue":"2","key":"e_1_3_3_51_1","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1001\/jama.2025.19615","article-title":"Metabolic dysfunction-associated steatotic liver disease in adults: a review","volume":"335","author":"Tilg H","year":"2026","unstructured":"Tilg H, Petta S, Stefan N, Targher G. Metabolic dysfunction-associated steatotic liver disease in adults: a review. JAMA. 2026;335(2):163\u2013174.","journal-title":"JAMA"},{"issue":"5","key":"e_1_3_3_52_1","doi-asserted-by":"crossref","first-page":"224","DOI":"10.14740\/gr2053","article-title":"Predictors of development of hepatocellular carcinoma in non-cirrhotic patients with metabolic dysfunction-associated steatotic liver disease\/metabolic dysfunction-associated steatohepatitis \u2013 a retrospective analysis of the national inpatient sample database","volume":"18","author":"Dhruv S","year":"2025","unstructured":"Dhruv S, Ginnaram S, Fonkam A, Boger J. Predictors of development of hepatocellular carcinoma in non-cirrhotic patients with metabolic dysfunction-associated steatotic liver disease\/metabolic dysfunction-associated steatohepatitis \u2013 a retrospective analysis of the national inpatient sample database. Gastroenterology Res. 2025;18(5):224\u2013231.","journal-title":"Gastroenterology Res"},{"issue":"6","key":"e_1_3_3_53_1","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.cmet.2026.02.018","article-title":"The many pathways driving liver inflammation in MASH","volume":"38","author":"Tilg H","year":"2026","unstructured":"Tilg H, Adolph TE, Romeo S, Loomba R. The many pathways driving liver inflammation in MASH. Cell Metab. 2026;38(6):1054\u20131074.","journal-title":"Cell Metab"},{"issue":"1","key":"e_1_3_3_54_1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.cmet.2024.12.001","article-title":"Advancing de novo lipogenesis: genetic and metabolic insights","volume":"37","author":"Hartig SM","year":"2025","unstructured":"Hartig SM, Herman MA. Advancing de novo lipogenesis: genetic and metabolic insights. Cell Metab. 2025;37(1):3\u20134.","journal-title":"Cell Metab"},{"issue":"1","key":"e_1_3_3_55_1","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.cmet.2025.11.015","article-title":"Dual inhibition of ACLY and ACSS2 by EVT0185 reduces steatosis, hepatic stellate cell activation, and fibrosis in mouse models of MASH","volume":"38","author":"Di Pastena F","year":"2026","unstructured":"Di Pastena F, Gautam J, Lally JSV, Fayyazi R, Grasset E, Bhattacharya D, Fidelito G, Ahmadi E, Townsend LK, Batchuluun B, et al. Dual inhibition of ACLY and ACSS2 by EVT0185 reduces steatosis, hepatic stellate cell activation, and fibrosis in mouse models of MASH. Cell Metab. 2026;38(1):33\u201349. e10.","journal-title":"Cell Metab"},{"issue":"8","key":"e_1_3_3_56_1","doi-asserted-by":"crossref","first-page":"104064","DOI":"10.1016\/j.drudis.2024.104064","article-title":"Unveiling the role of the Hedgehog signaling pathway in chronic liver disease: therapeutic insights and strategies","volume":"29","author":"Nair B","year":"2024","unstructured":"Nair B, Kamath AJ, Pradeep G, Devan AR, Sethi G, Nath LR. Unveiling the role of the Hedgehog signaling pathway in chronic liver disease: therapeutic insights and strategies. Drug Discov Today. 2024;29(8):104064.","journal-title":"Drug Discov Today"},{"issue":"11","key":"e_1_3_3_57_1","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1016\/j.cmet.2025.09.011","article-title":"The enedioic acid analog 326E alleviates metabolic dysfunction-associated steatohepatitis via dual targeting at ACLY and PPAR\u03b1","volume":"37","author":"Xie Z","year":"2025","unstructured":"Xie Z, Cheng L, Hu Y, Song G, Wang F, Zhang M, Zhang Y, Zhang X, Zhou C, Zhu X, et al. The enedioic acid analog 326E alleviates metabolic dysfunction-associated steatohepatitis via dual targeting at ACLY and PPAR\u03b1. Cell Metab. 2025;37(11):2149\u20132166.e9.","journal-title":"Cell Metab"},{"issue":"1","key":"e_1_3_3_58_1","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12950-025-00461-x","article-title":"Beyond energy: how TCA cycle-derived metabolites regulate gene expression and inflammation in the nucleus","volume":"22","author":"Randhawa J","year":"2025","unstructured":"Randhawa J, P\u00e5lsson-McDermott EM. Beyond energy: how TCA cycle-derived metabolites regulate gene expression and inflammation in the nucleus. J Inflamm (Lond). 2025;22(1):39.","journal-title":"J Inflamm (Lond)"},{"issue":"1","key":"e_1_3_3_59_1","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1186\/s41043-025-01054-3","article-title":"Global prevalence of dyslipidemias in the general adult population: a systematic review and meta-analysis","volume":"44","author":"Ballena-Caicedo J","year":"2025","unstructured":"Ballena-Caicedo J, Zuzunaga-Montoya FE, Loayza-Castro JA, V\u00e1squez-Romero LEM, Tapia-Limonchi R, De Carrillo CIG, Vera-Ponce VJ. Global prevalence of dyslipidemias in the general adult population: a systematic review and meta-analysis. J Health Popul Nutr. 2025;44(1):308.","journal-title":"J Health Popul Nutr"},{"issue":"1","key":"e_1_3_3_60_1","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cmet.2017.08.002","article-title":"Nonalcoholic Fatty Liver Disease as a Nexus of Metabolic and Hepatic Diseases","volume":"27","author":"Samuel VT","year":"2018","unstructured":"Samuel VT, Shulman GI. Nonalcoholic Fatty Liver Disease as a Nexus of Metabolic and Hepatic Diseases. Cell Metab. 2018;27(1):22\u201341.","journal-title":"Cell Metab"},{"issue":"2","key":"e_1_3_3_61_1","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/MOL.0000000000000390","article-title":"ATP-citrate lyase: genetics, molecular biology and therapeutic target for dyslipidemia","volume":"28","author":"Burke AC","year":"2017","unstructured":"Burke AC, Huff MW. ATP-citrate lyase: genetics, molecular biology and therapeutic target for dyslipidemia. Curr Opin Lipidol. 2017;28(2):193\u2013200.","journal-title":"Curr Opin Lipidol"},{"issue":"10","key":"e_1_3_3_62_1","doi-asserted-by":"crossref","first-page":"9557","DOI":"10.1074\/jbc.M310512200","article-title":"ATP-citrate lyase deficiency in the mouse","volume":"279","author":"Beigneux AP","year":"2004","unstructured":"Beigneux AP, Kosinski C, Gavino B, Horton JD, Skarnes WC, Young SG. ATP-citrate lyase deficiency in the mouse. J Biol Chem. 2004;279(10):9557\u20139564.","journal-title":"J Biol Chem"},{"issue":"6","key":"e_1_3_3_63_1","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.cmet.2022.05.004","article-title":"Inhibition of ATP-citrate lyase improves NASH, liver fibrosis, and dyslipidemia","volume":"34","author":"Morrow MR","year":"2022","unstructured":"Morrow MR, Batchuluun B, Wu J, Ahmadi E, Leroux JM, Mohammadi-Shemirani P, Desjardins EM, Wang Z, Tsakiridis EE, Lavoie DCT, et al. Inhibition of ATP-citrate lyase improves NASH, liver fibrosis, and dyslipidemia. Cell Metab. 2022;34(6):919\u2013936.e8.","journal-title":"Cell Metab"},{"issue":"15","key":"e_1_3_3_64_1","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1056\/NEJMoa2215024","article-title":"Bempedoic acid and cardiovascular outcomes in statin-intolerant patients","volume":"388","author":"Nissen SE","year":"2023","unstructured":"Nissen SE, Lincoff AM, Brennan D, Ray KK, Mason D, Kastelein JJP, Thompson PD, Libby P, Cho L, Plutzky J, et al. Bempedoic acid and cardiovascular outcomes in statin-intolerant patients. N Engl J Med. 2023;388(15):1353\u20131364.","journal-title":"N Engl J Med"},{"issue":"7","key":"e_1_3_3_65_1","doi-asserted-by":"crossref","first-page":"e011662","DOI":"10.1161\/JAHA.118.011662","article-title":"Efficacy and safety of bempedoic acid in patients with hypercholesterolemia and statin intolerance","volume":"8","author":"Laufs U","year":"2019","unstructured":"Laufs U, Banach M, Mancini GBJ, Gaudet D, Bloedon LT, Sterling LR, Kelly S, Stroes ESG. Efficacy and safety of bempedoic acid in patients with hypercholesterolemia and statin intolerance. J Am Heart Assoc. 2019;8(7):e011662.","journal-title":"J Am Heart Assoc"},{"key":"e_1_3_3_66_1","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.atherosclerosis.2018.06.002","article-title":"Efficacy and safety of bempedoic acid added to ezetimibe in statin-intolerant patients with hypercholesterolemia: A randomized, placebo-controlled study","volume":"277","author":"Ballantyne CM","year":"2018","unstructured":"Ballantyne CM, Banach M, Mancini GBJ, Lepor NE, Hanselman JC, Zhao X, Leiter LA. Efficacy and safety of bempedoic acid added to ezetimibe in statin-intolerant patients with hypercholesterolemia: A randomized, placebo-controlled study. Atherosclerosis. 2018;277:195\u2013203.","journal-title":"Atherosclerosis"},{"issue":"4","key":"e_1_3_3_67_1","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.cmet.2025.12.018","article-title":"Bempedoic acid directly binds and activates PPAR\u03b1","volume":"38","author":"Papa C","year":"2026","unstructured":"Papa C, Rose A, Martin HNG, Useini A, Geier F, Liao L, Rodr\u00edguez-Aguilera JR, Valina-Allo P, Hoffmann A, Tvardovskiy A, et al. Bempedoic acid directly binds and activates PPAR\u03b1. Cell Metab. 2026;38(4):824\u2013830.e5.","journal-title":"Cell Metab"},{"key":"e_1_3_3_68_1","doi-asserted-by":"crossref","first-page":"109392","DOI":"10.1016\/j.intimp.2022.109392","article-title":"Bempedoic acid, an ATP citrate lyase inhibitor, reduces intimal hyperplasia via activation of AMPK\u03b1 signaling pathway","volume":"113","author":"Liu W","year":"2022","unstructured":"Liu W, Liu M, Xiong H, Xia L, Yang Q, Chen M, Cai Y, Li S. Bempedoic acid, an ATP citrate lyase inhibitor, reduces intimal hyperplasia via activation of AMPK\u03b1 signaling pathway. Int Immunopharmacol. 2022;113(Pt A):109392.","journal-title":"Int Immunopharmacol"},{"issue":"11","key":"e_1_3_3_69_1","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1161\/ATVBAHA.123.319674","article-title":"Oxidized phospholipid oxPAPC alters regulatory T-cell differentiation and decreases their protective function in atherosclerosis in mice","volume":"43","author":"Appleton BD","year":"2023","unstructured":"Appleton BD, Palmer SA, Smith HP, Stephens LE, Major AS. Oxidized phospholipid oxPAPC alters regulatory T-cell differentiation and decreases their protective function in atherosclerosis in mice. Arterioscler Thromb Vasc Biol. 2023;43(11):2119\u20132132.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"e_1_3_3_70_1","doi-asserted-by":"crossref","first-page":"57","DOI":"10.4049\/immunohorizons.2300101","article-title":"Oxidized low-density lipoprotein accumulation in macrophages impairs lipopolysaccharide-induced activation of AKT2, ATP citrate lyase, acetyl-coenzyme a production, and inflammatory gene H3K27 acetylation","volume":"8","author":"Ting KKY","year":"2024","unstructured":"Ting KKY, Yu P, Iyayi M, Dow R, Hyduk SJ, Floro E, Ibrahim H, Karim S, Polenz CK, Winer DA, et al. Oxidized low-density lipoprotein accumulation in macrophages impairs lipopolysaccharide-induced activation of AKT2, ATP citrate lyase, acetyl-coenzyme a production, and inflammatory gene H3K27 acetylation. Immunohorizons. 2024;8(1):57\u201373.","journal-title":"Immunohorizons"},{"issue":"11","key":"e_1_3_3_71_1","doi-asserted-by":"crossref","first-page":"6166","DOI":"10.3390\/ijms23116166","article-title":"LXR\u03b1 regulates oxLDL-induced trained immunity in macrophages","volume":"23","author":"Findeisen HM","year":"2022","unstructured":"Findeisen HM, Voges VC, Braun LC, Sonnenberg J, Schwarz D, K\u00f6rner H, Reinecke H, Sohrabi Y. LXR\u03b1 regulates oxLDL-induced trained immunity in macrophages. Int J Mol Sci. 2022;23(11):6166.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"e_1_3_3_72_1","doi-asserted-by":"crossref","first-page":"e037898","DOI":"10.1161\/JAHA.124.037898","article-title":"Bempedoic acid for prevention of cardiovascular events in people with obesity: A CLEAR outcomes subset analysis","volume":"14","author":"Bays HE","year":"2025","unstructured":"Bays HE, Bloedon L, Brennan D, Lei L, Lincoff AM, Nicholls SJ, Plutzky J, Powell HA, Nissen SE. Bempedoic acid for prevention of cardiovascular events in people with obesity: A CLEAR outcomes subset analysis. J Am Heart Assoc. 2025;14(4):e037898.","journal-title":"J Am Heart Assoc"},{"issue":"10","key":"e_1_3_3_73_1","doi-asserted-by":"crossref","first-page":"103410","DOI":"10.1016\/j.autrev.2023.103410","article-title":"Immune-mediated inflammatory diseases: Common and different pathogenic and clinical features","volume":"22","author":"Monteleone G","year":"2023","unstructured":"Monteleone G, Moscardelli A, Colella A, Marafini I, Salvatori S. Immune-mediated inflammatory diseases: Common and different pathogenic and clinical features. Autoimmun Rev. 2023;22(10):103410.","journal-title":"Autoimmun Rev"},{"issue":"10","key":"e_1_3_3_74_1","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/s41577-021-00603-1","article-title":"Immune-mediated inflammatory disease therapeutics: past, present and future","volume":"21","author":"McInnes IB","year":"2021","unstructured":"McInnes IB, Gravallese EM. Immune-mediated inflammatory disease therapeutics: past, present and future. Nat Rev Immunol. 2021;21(10):680\u2013686.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"e_1_3_3_75_1","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1146\/annurev-pathmechdis-051222-015350","article-title":"Immune dysregulation in obesity","volume":"20","author":"Jiang Z","year":"2025","unstructured":"Jiang Z, Tabuchi C, Gayer SG, Bapat SP. Immune dysregulation in obesity. Annu Rev Pathol. 2025;20(1):483\u2013509.","journal-title":"Annu Rev Pathol"},{"issue":"1","key":"e_1_3_3_76_1","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1146\/annurev-nutr-111324-122456","article-title":"Obesity and autoimmunity epidemic: the role of immunometabolism","volume":"45","author":"Colamatteo A","year":"2025","unstructured":"Colamatteo A, Fusco C, Matarese A, Matarese G. Obesity and autoimmunity epidemic: the role of immunometabolism. Annu Rev Nutr. 2025;45(1):115\u2013140.","journal-title":"Annu Rev Nutr"},{"issue":"1","key":"e_1_3_3_77_1","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/oby.70044","article-title":"Obesity as a risk factor for autoimmune diseases: a systematic review and meta-analysis","volume":"34","author":"Spatocco I","year":"2026","unstructured":"Spatocco I, Mele G, De Rosa G, Fusco C, Ruggiero K, Pellegrini V, Carreras F, La Grotta R, Ceriello A, Procaccini C, et al. Obesity as a risk factor for autoimmune diseases: a systematic review and meta-analysis. Obesity (Silver Spring). 2026;34(1):36\u201350.","journal-title":"Obesity (Silver Spring)"},{"issue":"1","key":"e_1_3_3_78_1","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12967-025-07422-1","article-title":"Genetic pleiotropy underlying obesity and autoimmune disorders: a large-scale cross-trait gwas analysis in European ancestry populations","volume":"24","author":"Jiang X","year":"2025","unstructured":"Jiang X, Li S, Zhang S, Li J, Liu D, Zhao H. Genetic pleiotropy underlying obesity and autoimmune disorders: a large-scale cross-trait gwas analysis in European ancestry populations. J Transl Med. 2025;24(1):28.","journal-title":"J Transl Med"},{"key":"e_1_3_3_79_1","doi-asserted-by":"crossref","first-page":"1713148","DOI":"10.3389\/fimmu.2025.1713148","article-title":"Immunocyte lipid metabolic reprogramming: a novel pathway for targeted intervention in autoimmune diseases","volume":"16","author":"Cui Y","year":"2025","unstructured":"Cui Y, Feng Z, Zhao Q, Dai H, Zheng Y, Rui H, Liu B. Immunocyte lipid metabolic reprogramming: a novel pathway for targeted intervention in autoimmune diseases. Front Immunol. 2025;16:1713148.","journal-title":"Front Immunol"},{"issue":"1","key":"e_1_3_3_80_1","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/s42003-025-07917-z","article-title":"KLHL25-ACLY module functions as a switch in the fate determination of the differentiation of iTreg\/Th17","volume":"8","author":"Tian M","year":"2025","unstructured":"Tian M, Hao F, Jin X, Wang X, Chang T, He S, Wang H, Jiang Y, Wang Y, Liu J, et al. KLHL25-ACLY module functions as a switch in the fate determination of the differentiation of iTreg\/Th17. Commun Biol. 2025;8(1):471.","journal-title":"Commun Biol"},{"issue":"3","key":"e_1_3_3_81_1","doi-asserted-by":"crossref","first-page":"113518","DOI":"10.1016\/j.intimp.2024.113518","article-title":"Neutrophil extracellular traps in rheumatoid arthritis: Activating fibroblast-like synoviocytes via ATP citrate lyase","volume":"143","author":"Li J","year":"2024","unstructured":"Li J, Wang X, Tan M, Zheng J, Mao J, Hao J, Shen H. Neutrophil extracellular traps in rheumatoid arthritis: Activating fibroblast-like synoviocytes via ATP citrate lyase. Int Immunopharmacol. 2024;143(Pt 3):113518.","journal-title":"Int Immunopharmacol"},{"issue":"4","key":"e_1_3_3_82_1","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.3390\/ijms27041860","article-title":"Pathogenic drivers of difficult-to-treat rheumatoid arthritis: synovium and beyond","volume":"27","author":"Dorg\u00f3 AM","year":"2026","unstructured":"Dorg\u00f3 AM, Gunkl-T\u00f3th L, Nagy G. Pathogenic drivers of difficult-to-treat rheumatoid arthritis: synovium and beyond. Int J Mol Sci. 2026;27(4):1860.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"e_1_3_3_83_1","doi-asserted-by":"crossref","first-page":"e202451381","DOI":"10.1002\/eji.202451381","article-title":"Metabolic reprogramming in stromal and immune cells in rheumatoid arthritis and osteoarthritis: therapeutic possibilities","volume":"55","author":"Henry \u00d3C","year":"2025","unstructured":"Henry \u00d3C, O\u2019Neill LAJ. Metabolic reprogramming in stromal and immune cells in rheumatoid arthritis and osteoarthritis: therapeutic possibilities. Eur J Immunol. 2025;55(4):e202451381.","journal-title":"Eur J Immunol"},{"issue":"11","key":"e_1_3_3_84_1","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/s41423-024-01212-3","article-title":"RBM25 is required to restrain inflammation via ACLY RNA splicing-dependent metabolism rewiring","volume":"21","author":"Zhang Y","year":"2024","unstructured":"Zhang Y, Gao Y, Wang Y, Jiang Y, Xiang Y, Wang X, Wang Z, Ding Y, Chen H, Rui B, et al. RBM25 is required to restrain inflammation via ACLY RNA splicing-dependent metabolism rewiring. Cell Mol Immunol. 2024;21(11):1231\u20131250.","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"e_1_3_3_85_1","doi-asserted-by":"crossref","first-page":"2560019","DOI":"10.1080\/19490976.2025.2560019","article-title":"Regulatory roles of intestinal CD4(+) T cells in inflammation and their modulation by the intestinal microbiota","volume":"17","author":"Ma Z","year":"2025","unstructured":"Ma Z, Wang Z, Cao J, Dong Y, Chen Y. Regulatory roles of intestinal CD4(+) T cells in inflammation and their modulation by the intestinal microbiota. Gut Microbes. 2025;17(1):2560019.","journal-title":"Gut Microbes"},{"key":"e_1_3_3_86_1","doi-asserted-by":"crossref","first-page":"1651063","DOI":"10.3389\/fimmu.2025.1651063","article-title":"Th17\/Treg imbalance in inflammatory bowel disease: immunological mechanisms and microbiota-driven regulation","volume":"16","author":"Hu Y","year":"2025","unstructured":"Hu Y, Yang Y, Li Y, Zhang Q, Zhang W, Jia J, Han Z, Wang J. Th17\/Treg imbalance in inflammatory bowel disease: immunological mechanisms and microbiota-driven regulation. Front Immunol. 2025;16:1651063.","journal-title":"Front Immunol"},{"issue":"30","key":"e_1_3_3_87_1","doi-asserted-by":"crossref","first-page":"e00461","DOI":"10.1002\/advs.202500461","article-title":"ACSS2-Mediated histone H4 Lysine 12 crotonylation (H4K12cr) alleviates colitis via enhancing transcription of CLDN7","volume":"12","author":"Yuan M","year":"2025","unstructured":"Yuan M, Chen S, Lin Z, Yu R, Chao K, Ye S, Li Q, Ke H, Zhang C, Huang J, et al. ACSS2-Mediated histone H4 Lysine 12 crotonylation (H4K12cr) alleviates colitis via enhancing transcription of CLDN7. Adv Sci (Weinh). 2025;12(30):e00461.","journal-title":"Adv Sci (Weinh)"},{"issue":"8","key":"e_1_3_3_88_1","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s12032-025-02909-9","article-title":"The metabolic significance of ATP-citrate lyase in cancer: insights into glutamine-fuelled citrate biosynthesis and tumour progression","volume":"42","author":"Bader M","year":"2025","unstructured":"Bader M, Galy O, Babiker M, Eletr L, Saeed M, Suliman O, Abdel Hamid MM. The metabolic significance of ATP-citrate lyase in cancer: insights into glutamine-fuelled citrate biosynthesis and tumour progression. Med Oncol. 2025;42(8):349.","journal-title":"Med Oncol"},{"issue":"6","key":"e_1_3_3_89_1","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.3724\/abbs.2026028","article-title":"ATP-citrate lyase: carcinogenesis and therapeutic advances","volume":"58","author":"Meng L","year":"2026","unstructured":"Meng L, Wang Y, Cai Q, Xi Y, Sun D, Zhao M, Chen Q. ATP-citrate lyase: carcinogenesis and therapeutic advances. Acta Biochim Biophys Sin (Shanghai). 2026;58(6):1223\u20131234.","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"issue":"4","key":"e_1_3_3_90_1","doi-asserted-by":"crossref","first-page":"e12427","DOI":"10.1002\/jev2.12427","article-title":"The small extracellular vesicle-mediated intercellular transformation of CXCR1(Low) to CXCR1(High) tumour cells promotes the progression of head and neck squamous cell carcinoma","volume":"13","author":"Xu Q","year":"2024","unstructured":"Xu Q, Cheng A, Li B, Tian X, Han Z, Feng Z. The small extracellular vesicle-mediated intercellular transformation of CXCR1(Low) to CXCR1(High) tumour cells promotes the progression of head and neck squamous cell carcinoma. J Extracell Vesicles. 2024;13(4):e12427.","journal-title":"J Extracell Vesicles"},{"issue":"3","key":"e_1_3_3_91_1","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1158\/2159-8290.CD-18-0567","article-title":"Acetyl-CoA metabolism supports multistep pancreatic tumorigenesis","volume":"9","author":"Carrer A","year":"2019","unstructured":"Carrer A, Trefely S, Zhao S, Campbell SL, Norgard RJ, Schultz KC, Sidoli S, Parris JLD, Affronti HC, Sivanand S, et al. Acetyl-CoA metabolism supports multistep pancreatic tumorigenesis. Cancer Discov. 2019;9(3):416\u2013435.","journal-title":"Cancer Discov"},{"issue":"4","key":"e_1_3_3_92_1","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.molcel.2013.07.002","article-title":"Acetylation stabilizes ATP-citrate lyase to promote lipid biosynthesis and tumor growth","volume":"51","author":"Lin R","year":"2013","unstructured":"Lin R, Tao R, Gao X, Li T, Zhou X, Guan K-L, Xiong Y, Lei Q-Y. Acetylation stabilizes ATP-citrate lyase to promote lipid biosynthesis and tumor growth. Mol Cell. 2013;51(4):506\u2013518.","journal-title":"Mol Cell"},{"issue":"7","key":"e_1_3_3_93_1","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/j.molcel.2025.02.024","article-title":"PI3K\u03b2 functions as a protein kinase to promote cellular protein O-GlcNAcylation and acetyl-CoA production for tumor growth","volume":"85","author":"He X","year":"2025","unstructured":"He X, Chen D, Liu G, Wu Q, Zhao H, Guo D, Jiang X, Li M, Meng Y, Yin Y, et al. PI3K\u03b2 functions as a protein kinase to promote cellular protein O-GlcNAcylation and acetyl-CoA production for tumor growth. Mol Cell. 2025;85(7):1411\u20131425.e8.","journal-title":"Mol Cell"},{"issue":"5","key":"e_1_3_3_94_1","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.tcb.2025.04.002","article-title":"New job for an old tool: PI3K\u03b2 phosphorylates OGT to regulate acetyl-CoA in glioblastoma","volume":"35","author":"Young RG","year":"2025","unstructured":"Young RG, Ahmed NN, Reginato MJ. New job for an old tool: PI3K\u03b2 phosphorylates OGT to regulate acetyl-CoA in glioblastoma. Trends Cell Biol. 2025;35(5):361\u2013363.","journal-title":"Trends Cell Biol"},{"issue":"1","key":"e_1_3_3_95_1","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/s41392-025-02395-5","article-title":"Focal adhesion kinase\/Src family kinase axis-mediated tyrosine phosphorylation of metabolic enzymes facilitates tumor metastasis","volume":"10","author":"Chen J","year":"2025","unstructured":"Chen J, Zhang J, Zhu Y, Zhu Y, Pang J, Wu Q, Wang Y, Zhan Q. Focal adhesion kinase\/Src family kinase axis-mediated tyrosine phosphorylation of metabolic enzymes facilitates tumor metastasis. Signal Transduct Target Ther. 2025;10(1):280.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"e_1_3_3_96_1","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s13046-023-02656-7","article-title":"Activation of ACLY by SEC63 deploys metabolic reprogramming to facilitate hepatocellular carcinoma metastasis upon endoplasmic reticulum stress","volume":"42","author":"Hu C","year":"2023","unstructured":"Hu C, Xin Z, Sun X, Hu Y, Zhang C, Yan R, Wang Y, Lu M, Huang J, Du X, et al. Activation of ACLY by SEC63 deploys metabolic reprogramming to facilitate hepatocellular carcinoma metastasis upon endoplasmic reticulum stress. J Exp Clin Cancer Res. 2023;42(1):108.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"e_1_3_3_97_1","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/s42003-026-09954-8","article-title":"Cholesterol synthases suppress metastasis and stemness through PDIA4\/ACLY or SYVN1\/SCD1 axis in advanced colorectal cancer","volume":"9","author":"Li W","year":"2026","unstructured":"Li W, Lin M, Zhao Y, Tang Y, Chen Y, He L. Cholesterol synthases suppress metastasis and stemness through PDIA4\/ACLY or SYVN1\/SCD1 axis in advanced colorectal cancer. Commun Biol. 2026;9(1):795.","journal-title":"Commun Biol"},{"issue":"6","key":"e_1_3_3_98_1","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1038\/s41418-025-01644-y","article-title":"P4HA3 drives cervical cancer lymphatic metastasis by facilitating ACLY-mediated ferroptosis resistance","volume":"33","author":"Yuan L","year":"2026","unstructured":"Yuan L, Jiang H, Xia M, Wen W, Fan H, Liu S, Liao Y, Liu P, Jia Y, Zhao X, et al. P4HA3 drives cervical cancer lymphatic metastasis by facilitating ACLY-mediated ferroptosis resistance. Cell Death Differ. 2026;33(6):1120\u20131135.","journal-title":"Cell Death Differ"},{"issue":"7","key":"e_1_3_3_99_1","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/s41419-024-06951-9","article-title":"Chemotherapy-induced acetylation of ACLY by NAT10 promotes its nuclear accumulation and acetyl-CoA production to drive chemoresistance in hepatocellular carcinoma","volume":"15","author":"Wang Y","year":"2024","unstructured":"Wang Y, Su K, Wang C, Deng T, Liu X, Sun S, Jiang Y, Zhang C, Xing B, Du X, et al. Chemotherapy-induced acetylation of ACLY by NAT10 promotes its nuclear accumulation and acetyl-CoA production to drive chemoresistance in hepatocellular carcinoma. Cell Death Dis. 2024;15(7):545.","journal-title":"Cell Death Dis"},{"issue":"1","key":"e_1_3_3_100_1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00109-019-01863-0","article-title":"The vital role of ATP citrate lyase in chronic diseases","volume":"98","author":"Khwairakpam AD","year":"2020","unstructured":"Khwairakpam AD, Banik K, Girisa S, Shabnam B, Shakibaei M, Fan L, Arfuso F, Monisha J, Wang H, Mao X, et al. The vital role of ATP citrate lyase in chronic diseases. J Mol Med (Berl). 2020;98(1):71\u201395.","journal-title":"J Mol Med (Berl)"},{"key":"e_1_3_3_101_1","doi-asserted-by":"crossref","first-page":"156436","DOI":"10.1016\/j.metabol.2025.156436","article-title":"Targeting lipid metabolism in neurodegenerative diseases: From experimental to clinical","volume":"175","author":"Long J","year":"2026","unstructured":"Long J, Liu S, Shi Y, Zhang C, Qin L, Ai Q. Targeting lipid metabolism in neurodegenerative diseases: From experimental to clinical. Metabolism. 2026;175:156436.","journal-title":"Metabolism"},{"key":"e_1_3_3_102_1","doi-asserted-by":"crossref","first-page":"103159","DOI":"10.1016\/j.arr.2026.103159","article-title":"Lipid dysregulation as a central contributor of neurodegenerative diseases: Emerging therapeutic targets and strategies","volume":"119","author":"Zhang J","year":"2026","unstructured":"Zhang J, Wang C, Li Y, Xiao Z, Cai Z, Qian Y, Shi L, Zhang Q. Lipid dysregulation as a central contributor of neurodegenerative diseases: Emerging therapeutic targets and strategies. Ageing Res Rev. 2026;119:103159.","journal-title":"Ageing Res Rev"},{"issue":"12","key":"e_1_3_3_103_1","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1016\/j.neuron.2025.03.028","article-title":"Alpha-synuclein mutations mislocalize cytoplasmic p300 compromising autophagy, which is rescued by ACLY inhibition","volume":"113","author":"Son SM","year":"2025","unstructured":"Son SM, Siddiqi FH, Lopez A, Ansari R, Tyrkalska SD, Park SJ, Kunath T, Metzakopian E, Fleming A, Rubinsztein DC, et al. Alpha-synuclein mutations mislocalize cytoplasmic p300 compromising autophagy, which is rescued by ACLY inhibition. Neuron. 2025;113(12):1908\u20131924.e13.","journal-title":"Neuron"},{"issue":"21","key":"e_1_3_3_104_1","doi-asserted-by":"crossref","first-page":"7583","DOI":"10.1016\/S0021-9258(17)41006-4","article-title":"Reactivity and inhibitor potential of hydroxycitrate isomers with citrate synthase, citrate lyase, and ATP citrate lyase","volume":"252","author":"Sullivan AC","year":"1977","unstructured":"Sullivan AC, Singh M, Srere PA, Glusker JP. Reactivity and inhibitor potential of hydroxycitrate isomers with citrate synthase, citrate lyase, and ATP citrate lyase. J Biol Chem. 1977;252(21):7583\u20137590.","journal-title":"J Biol Chem"},{"issue":"4","key":"e_1_3_3_105_1","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0031-9422(00)86224-X","article-title":"(\u2212)-Hydroxycitric acid\u2014the principal acid in the fruits of Garcinia cambogia desr","volume":"4","author":"Lewis YS","year":"1965","unstructured":"Lewis YS, Neelakantan S. (\u2212)-Hydroxycitric acid\u2014the principal acid in the fruits of Garcinia cambogia desr. Phytochemistry. 1965;4(4):619\u2013625.","journal-title":"Phytochemistry"},{"issue":"1","key":"e_1_3_3_106_1","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1432-1033.1973.tb03038.x","article-title":"Inhibition of enzymes which interact with citrate by (\u2013)hydroxycitrate and 1,2,3,-tricarboxybenzene","volume":"38","author":"Cheema-Dhadli S","year":"1973","unstructured":"Cheema-Dhadli S, Halperin ML, Leznoff CC. Inhibition of enzymes which interact with citrate by (\u2013)hydroxycitrate and 1,2,3,-tricarboxybenzene. Eur J Biochem. 1973;38(1):98\u2013102.","journal-title":"Eur J Biochem"},{"issue":"3","key":"e_1_3_3_107_1","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/j.1432-1033.1991.tb16448.x","article-title":"Synthesis and evaluation of (+) and (\u2212)\u20102,2\u2010difluorocitrate as inhibitors of rat\u2010liver ATP\u2010citrate lyase and porcine\u2010heart aconitase","volume":"202","author":"Saxty BA","year":"1991","unstructured":"Saxty BA, Novelli R, Dolle RE, Kruse LI, Reid DG, Camilleri P, et al. Synthesis and evaluation of (+) and (\u2212)\u20102,2\u2010difluorocitrate as inhibitors of rat\u2010liver ATP\u2010citrate lyase and porcine\u2010heart aconitase. Eur J Biochem. 1991;202(3):889\u2013896.","journal-title":"Eur J Biochem"},{"issue":"26","key":"e_1_3_3_108_1","doi-asserted-by":"crossref","first-page":"4875","DOI":"10.1021\/jm00104a014","article-title":"ATP-citrate lyase as a target for hypolipidemic intervention. Sulfoximine and 3-hydroxy-beta-lactam containing analogues of citric acid as potential tight-binding inhibitors","volume":"35","author":"Dolle RE","year":"1992","unstructured":"Dolle RE, McNair D, Hughes MJ, Kruse LI, Eggelston D, Saxty BA, Wells TN, Groot PH. ATP-citrate lyase as a target for hypolipidemic intervention. Sulfoximine and 3-hydroxy-beta-lactam containing analogues of citric acid as potential tight-binding inhibitors. J Med Chem. 1992;35(26):4875\u20134884.","journal-title":"J Med Chem"},{"issue":"3","key":"e_1_3_3_109_1","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1021\/jm00003a016","article-title":"Synthesis of novel thiol-containing citric acid analogues. Kinetic evaluation of these and other potential active-site-directed and mechanism-based inhibitors of ATP citrate lyase","volume":"38","author":"Dolle RE","year":"1995","unstructured":"Dolle RE, Gribble A, Wilkes T, Kruse LI, Eggleston D, Saxty BA, Wells TN, Groot PH. Synthesis of novel thiol-containing citric acid analogues. Kinetic evaluation of these and other potential active-site-directed and mechanism-based inhibitors of ATP citrate lyase. J Med Chem. 1995;38(3):537\u2013543.","journal-title":"J Med Chem"},{"issue":"18","key":"e_1_3_3_110_1","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1021\/jm960167w","article-title":"ATP-citrate lyase as a target for hypolipidemic intervention. Design and synthesis of 2-substituted butanedioic acids as novel, potent inhibitors of the enzyme","volume":"39","author":"Gribble AD","year":"1996","unstructured":"Gribble AD, Dolle RE, Shaw A, McNair D, Novelli R, Novelli CE, Slingsby BP, Shah VP, Tew D, Saxty BA, et al. ATP-citrate lyase as a target for hypolipidemic intervention. Design and synthesis of 2-substituted butanedioic acids as novel, potent inhibitors of the enzyme. J Med Chem. 1996;39(18):3569\u20133584.","journal-title":"J Med Chem"},{"issue":"19","key":"e_1_3_3_111_1","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1021\/jm980091z","article-title":"ATP-Citrate lyase as a target for hypolipidemic intervention. 2. Synthesis and evaluation of (3R,5S)-omega-substituted-3-carboxy-3, 5-dihydroxyalkanoic acids and their gamma-lactone prodrugs as inhibitors of the enzyme in vitro and in vivo","volume":"41","author":"Gribble AD","year":"1998","unstructured":"Gribble AD, Ife RJ, Shaw A, McNair D, Novelli CE, Bakewell S, Shah VP, Dolle RE, Groot PH, Pearce N, et al. ATP-Citrate lyase as a target for hypolipidemic intervention. 2. Synthesis and evaluation of (3R,5S)-omega-substituted-3-carboxy-3, 5-dihydroxyalkanoic acids and their gamma-lactone prodrugs as inhibitors of the enzyme in vitro and in vivo. J Med Chem. 1998;41(19):3582\u20133595.","journal-title":"J Med Chem"},{"issue":"1","key":"e_1_3_3_112_1","first-page":"113","article-title":"The role of ATP citrate-lyase in the metabolic regulation of plasma lipids. Hypolipidaemic effects of SB-204990, a lactone prodrug of the potent ATP citrate-lyase inhibitor SB-201076","volume":"334","author":"Pearce NJ","year":"1998","unstructured":"Pearce NJ, Yates JW, Berkhout TA, Jackson B, Tew D, Boyd H, Camilleri P, Sweeney P, Gribble AD, Shaw A, et al. The role of ATP citrate-lyase in the metabolic regulation of plasma lipids. Hypolipidaemic effects of SB-204990, a lactone prodrug of the potent ATP citrate-lyase inhibitor SB-201076. Biochem J. 1998;334(Pt 1):113\u2013119.","journal-title":"Biochem J"},{"issue":"14","key":"e_1_3_3_113_1","doi-asserted-by":"crossref","first-page":"8404","DOI":"10.1016\/S0021-9258(17)39488-7","article-title":"Inhibition of lipid synthesis by beta beta\u2019-tetramethyl-substituted, C14-C22, alpha, omega-dicarboxylic acids in the rat in vivo","volume":"260","author":"Bar-Tana J","year":"1985","unstructured":"Bar-Tana J, Rose-Kahn G, Srebnik M. Inhibition of lipid synthesis by beta beta\u2019-tetramethyl-substituted, C14-C22, alpha, omega-dicarboxylic acids in the rat in vivo. J Biol Chem. 1985;260(14):8404\u20138410.","journal-title":"J Biol Chem"},{"issue":"11","key":"e_1_3_3_114_1","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1161\/01.ATV.13.11.1580","article-title":"Effect of 3-thiadicarboxylic acid on lipid metabolism in experime ntal nephrosis","volume":"13","author":"Al-Shurbaji A","year":"1993","unstructured":"Al-Shurbaji A, Skorve J, Berge RK, Rudling M, Bj\u00f6rkhem I, Berglund L. Effect of 3-thiadicarboxylic acid on lipid metabolism in experime ntal nephrosis. Arterioscler Thromb. 1993;13(11):1580\u20131586.","journal-title":"Arterioscler Thromb"},{"issue":"7","key":"e_1_3_3_115_1","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s40265-020-01308-w","article-title":"Bempedoic acid: first approval","volume":"80","author":"Markham A.","year":"2020","unstructured":"Markham A. Bempedoic acid: first approval. Drugs. 2020;80(7):747\u2013753.","journal-title":"Drugs"},{"key":"e_1_3_3_116_1","doi-asserted-by":"crossref","first-page":"13457","DOI":"10.1038\/ncomms13457","article-title":"Liver-specific ATP-citrate lyase inhibition by bempedoic acid decreases LDL-C and attenuates atherosclerosis","volume":"7","author":"Pinkosky SL","year":"2016","unstructured":"Pinkosky SL, Newton RS, Day EA, Ford RJ, Lhotak S, Austin RC, Birch CM, Smith BK, Filippov S, Groot PHE, et al. Liver-specific ATP-citrate lyase inhibition by bempedoic acid decreases LDL-C and attenuates atherosclerosis. Nat Commun. 2016;7:13457.","journal-title":"Nat Commun"},{"issue":"22","key":"e_1_3_3_117_1","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1002\/cjoc.202200362","article-title":"Discovery of Novel Long\u2010Chain Alkenyl Diacid Derivatives as ACLY Inhibitors","volume":"40","author":"Song G","year":"2022","unstructured":"Song G, Cao L, Zhang M, Yang Y, Ma J, Xie Z, Li J, Nan F. Discovery of Novel Long\u2010Chain Alkenyl Diacid Derivatives as ACLY Inhibitors. Chin J Chem. 2022;40(22):2663\u20132670.","journal-title":"Chin J Chem"},{"issue":"15","key":"e_1_3_3_118_1","doi-asserted-by":"crossref","first-page":"15598","DOI":"10.1021\/acs.jmedchem.5c00480","article-title":"Discovery of novel tridentate alkenyl diacid derivatives as potent atp citrate lyase inhibitors for the treatment of hepatocellular carcinoma","volume":"68","author":"Yang Y","year":"2025","unstructured":"Yang Y, Zhai J, Wang F, Song G, Xu H, Sun X, Zhang Q, Ma J, Gu M, Gao Y, et al. Discovery of novel tridentate alkenyl diacid derivatives as potent atp citrate lyase inhibitors for the treatment of hepatocellular carcinoma. J Med Chem. 2025;68(15):15598\u201315616.","journal-title":"J Med Chem"},{"issue":"2","key":"e_1_3_3_119_1","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.apsb.2022.06.011","article-title":"Development of the novel ACLY inhibitor 326E as a promising treatment for hypercholesterolemia","volume":"13","author":"Xie Z","year":"2023","unstructured":"Xie Z, Zhang M, Song Q, Cheng L, Zhang X, Song G, Sun X, Gu M, Zhou C, Zhang Y, et al. Development of the novel ACLY inhibitor 326E as a promising treatment for hypercholesterolemia. Acta Pharm Sin B. 2023;13(2):739\u2013753.","journal-title":"Acta Pharm Sin B"},{"issue":"11","key":"e_1_3_3_120_1","doi-asserted-by":"crossref","first-page":"3208","DOI":"10.1016\/j.bmcl.2007.03.017","article-title":"2-Hydroxy-N-arylbenzenesulfonamides as ATP-citrate lyase inhibitors","volume":"17","author":"Li JJ","year":"2007","unstructured":"Li JJ, Wang H, Tino JA, Robl JA, Herpin TF, Lawrence RM, Biller S, Jamil H, Ponticiello R, Chen L, et al. 2-Hydroxy-N-arylbenzenesulfonamides as ATP-citrate lyase inhibitors. Bioorg Med Chem Lett. 2007;17(11):3208\u20133211.","journal-title":"Bioorg Med Chem Lett"},{"issue":"3","key":"e_1_3_3_121_1","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1111\/jcmm.16235","article-title":"ATP citrate lyase inhibitor triggers endoplasmic reticulum stress to induce hepatocellular carcinoma cell apoptosis via p\u2010eIF2\u03b1\/ATF4\/CHOP axis","volume":"25","author":"Zheng Y","year":"2021","unstructured":"Zheng Y, Zhou Q, Zhao C, Li J, Yu Z, Zhu Q. ATP citrate lyase inhibitor triggers endoplasmic reticulum stress to induce hepatocellular carcinoma cell apoptosis via p\u2010eIF2\u03b1\/ATF4\/CHOP axis. J Cell Mol Med. 2021;25(3):1468\u20131479.","journal-title":"J Cell Mol Med"},{"issue":"12","key":"e_1_3_3_122_1","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1021\/acs.jcim.2c00345","article-title":"Discovery of a novel macrocyclic ATP citrate lyase inhibitor","volume":"62","author":"Zang Y","year":"2022","unstructured":"Zang Y, Tai L, Hu Y, Wang Y, Sun H, Wen X, Yuan H, Dai L. Discovery of a novel macrocyclic ATP citrate lyase inhibitor. J Chem Inf Model. 2022;62(12):3123\u20133132.","journal-title":"J Chem Inf Model"},{"key":"e_1_3_3_123_1","doi-asserted-by":"crossref","first-page":"117684","DOI":"10.1016\/j.ejmech.2025.117684","article-title":"Design, synthesis, and biological evaluation of novel macrocyclic derivatives as potent ATP-citrate lyase inhibitors","volume":"292","author":"Zang Y","year":"2025","unstructured":"Zang Y, Shi M, Tai L, Hu Y, Wang Y, Zheng R, Feng Z, Yuan H, Wen X, Dai L, et al. Design, synthesis, and biological evaluation of novel macrocyclic derivatives as potent ATP-citrate lyase inhibitors. Eur J Med Chem. 2025;292:117684.","journal-title":"Eur J Med Chem"},{"issue":"22","key":"e_1_3_3_124_1","doi-asserted-by":"crossref","first-page":"5243","DOI":"10.3390\/molecules25225243","article-title":"Important flavonoids and their role as a therapeutic agent","volume":"25","author":"Ullah A","year":"2020","unstructured":"Ullah A, Munir S, Badshah SL, Khan N, Ghani L, Poulson BG, Emwas A-H, Jaremko M. Important flavonoids and their role as a therapeutic agent. Molecules. 2020;25(22):5243.","journal-title":"Molecules"},{"issue":"18","key":"e_1_3_3_125_1","doi-asserted-by":"crossref","first-page":"10406","DOI":"10.3390\/ijms231810747","article-title":"Discovery of flavonoids as novel inhibitors of ATP citrate lyase: structure-activity relationship and inhibition profiles","volume":"23","author":"Wang P","year":"2022","unstructured":"Wang P, Hou T, Xu F, Luo F, Zhou H, Liu F, Xie X, Liu Y, Wang J, Guo Z, et al. Discovery of flavonoids as novel inhibitors of ATP citrate lyase: structure-activity relationship and inhibition profiles. Int J Mol Sci. 2022;23(18):10406.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"e_1_3_3_126_1","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1023\/A:1016368912659","article-title":"The hypolipidemic activity of furoic acid and furylacrylic acid derivatives in rodents","volume":"2","author":"Hall IH","year":"1985","unstructured":"Hall IH, Williams WL, Rhyne KA, Knowles M. The hypolipidemic activity of furoic acid and furylacrylic acid derivatives in rodents. Pharm Res. 1985;2(5):233\u2013238.","journal-title":"Pharm Res"},{"issue":"4","key":"e_1_3_3_127_1","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.bmcl.2017.01.001","article-title":"Discovery of furan carboxylate derivatives as novel inhibitors of ATP-citrate lyase via virtual high-throughput screening","volume":"27","author":"Jernigan FE","year":"2017","unstructured":"Jernigan FE, Hanai JI, Sukhatme VP, Sun L. Discovery of furan carboxylate derivatives as novel inhibitors of ATP-citrate lyase via virtual high-throughput screening. Bioorg Med Chem Lett. 2017;27(4):929\u2013935.","journal-title":"Bioorg Med Chem Lett"},{"issue":"1","key":"e_1_3_3_128_1","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/ddr.430360106","article-title":"Anthrones, naturally occurring competitive inhibitors of adenosine-triphosphate-citrate lyase","volume":"36","author":"Oleynek JJ","year":"1995","unstructured":"Oleynek JJ, Barrow CJ, Burns MP, Sedlock DM, Murphy DJ, Kaplita PV, Sun HH, Cooper R, Gillum AM, Chadwick CC, et al. Anthrones, naturally occurring competitive inhibitors of adenosine-triphosphate-citrate lyase. Drug Dev Res. 1995;36(1):35\u201342.","journal-title":"Drug Dev Res"},{"key":"e_1_3_3_129_1","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.ejmech.2016.12.018","article-title":"Design and synthesis of emodin derivatives as novel inhibitors of ATP-citrate lyase","volume":"126","author":"Koerner SK","year":"2017","unstructured":"Koerner SK, Hanai J-I, Bai S, Jernigan FE, Oki M, Komaba C, Shuto E, Sukhatme VP, Sun L. Design and synthesis of emodin derivatives as novel inhibitors of ATP-citrate lyase. Eur J Med Chem. 2017;126:920\u2013928.","journal-title":"Eur J Med Chem"},{"key":"e_1_3_3_130_1","doi-asserted-by":"crossref","first-page":"106025","DOI":"10.1016\/j.fitote.2024.105956","article-title":"Discovery and characterization of novel ATP citrate lyase inhibitors from Acanthopanax senticosus (Rupr. & Maxim.) Harms","volume":"175","author":"Wang P","year":"2024","unstructured":"Wang P, Guo X, Hou T, Luo F, Li M, Wang X, et al. Discovery and characterization of novel ATP citrate lyase inhibitors from Acanthopanax senticosus (Rupr. & Maxim.) Harms. Fitoterapia. 2024;175:106025.","journal-title":"Fitoterapia"},{"key":"e_1_3_3_131_1","doi-asserted-by":"crossref","first-page":"110199","DOI":"10.1016\/j.cbi.2022.110199","article-title":"Discovery and characterization of novel ATP citrate lyase inhibitors from natural products by a luminescence-based assay","volume":"367","author":"Wang P","year":"2022","unstructured":"Wang P, Peng X, Hou T, Xu F, Zhou H, Yu Y, Qiu M, Liu Y, Zhao Y, Guo Z, et al. Discovery and characterization of novel ATP citrate lyase inhibitors from natural products by a luminescence-based assay. Chem Biol Interact. 2022;367:110199.","journal-title":"Chem Biol Interact"},{"key":"e_1_3_3_132_1","doi-asserted-by":"crossref","first-page":"118796","DOI":"10.1016\/j.ejmech.2026.118796","article-title":"Design and synthesis of novel ATP-citrate lyase inhibitors and their effects on MAFLD\/MASH","volume":"310","author":"Xu X","year":"2026","unstructured":"Xu X, Wang Z, Wen H, Xie X, Hou T, Luo F, Zhou H, Wang J, Zhao Y, Liang X, et al. Design and synthesis of novel ATP-citrate lyase inhibitors and their effects on MAFLD\/MASH. Eur J Med Chem. 2026;310:118796.","journal-title":"Eur J Med Chem"},{"issue":"9","key":"e_1_3_3_133_1","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1021\/jo00061a031","article-title":"Purpurone, an inhibitor of ATP-citrate lyase: a novel alkaloid from the marine sponge Iotrochota sp","volume":"58","author":"Chan GW","year":"1993","unstructured":"Chan GW, Francis T, Thureen DR, Offen PH, Pierce NJ, Westley JW, Johnson RK, Faulkner DJ. Purpurone, an inhibitor of ATP-citrate lyase: a novel alkaloid from the marine sponge Iotrochota sp. J Org Chem. 1993;58(9):2544\u20132546.","journal-title":"J Org Chem"},{"issue":"9","key":"e_1_3_3_134_1","doi-asserted-by":"crossref","first-page":"729","DOI":"10.7164\/antibiotics.50.729","article-title":"Antimycins, inhibitors of ATP-citrate lyase, from a Streptomyces sp","volume":"50","author":"Barrow CJ","year":"1997","unstructured":"Barrow CJ, Oleynek JJ, Marinelli V, Sun HH, Kaplita P, Sedlock DM, Gillum AM, Chadwick CC, Cooper R. Antimycins, inhibitors of ATP-citrate lyase, from a Streptomyces sp. J Antibiot (Tokyo). 1997;50(9):729\u2013733.","journal-title":"J Antibiot (Tokyo)"},{"issue":"50","key":"e_1_3_3_135_1","doi-asserted-by":"crossref","first-page":"39231","DOI":"10.1074\/jbc.M006192200","article-title":"Radicicol binds and inhibits mammalian ATP citrate lyase","volume":"275","author":"Ki SW","year":"2000","unstructured":"Ki SW, Ishigami K, Kitahara T, Kasahara K, Yoshida M, Horinouchi S. Radicicol binds and inhibits mammalian ATP citrate lyase. J Biol Chem. 2000;275(50):39231\u201339236.","journal-title":"J Biol Chem"},{"issue":"1","key":"e_1_3_3_136_1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.canlet.2014.03.015","article-title":"Inactivation of ATP citrate lyase by Cucurbitacin B: A bioactive compound from cucumber, inhibits prostate cancer growth","volume":"349","author":"Gao Y","year":"2014","unstructured":"Gao Y, Islam MS, Tian J, Lui VW, Xiao D. Inactivation of ATP citrate lyase by Cucurbitacin B: A bioactive compound from cucumber, inhibits prostate cancer growth. Cancer Lett. 2014;349(1):15\u201325.","journal-title":"Cancer Lett"},{"key":"e_1_3_3_137_1","doi-asserted-by":"crossref","first-page":"114581","DOI":"10.1016\/j.phytochem.2025.114581","article-title":"Discovery of potent ATP citrate lyase inhibitors from Tripterygium wilfordii Hook. f.: a structural and bioactivity analysis","volume":"239","author":"Qu B","year":"2025","unstructured":"Qu B, Wang J, Li Y, Hou T, Li X, Liu D, Han Y, Guo Z, Luo F, Huang F, et al. Discovery of potent ATP citrate lyase inhibitors from Tripterygium wilfordii Hook. f.: a structural and bioactivity analysis. Phytochemistry. 2025;239:114581.","journal-title":"Phytochemistry"},{"issue":"10","key":"e_1_3_3_138_1","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1080\/14786419.2023.2219816","article-title":"Identification of lignans as ATP citrate lyase (ACLY) inhibitors from the roots of Pouzolzia zeylanica","volume":"38","author":"Li J-L","year":"2024","unstructured":"Li J-L, Jiang J-Y, Gu S-S, Zhang L, Sun Y, Wang X-H, Li D-Y, Chen Z-Y, Jiang S-S, Zhu W-Z, et al. Identification of lignans as ATP citrate lyase (ACLY) inhibitors from the roots of Pouzolzia zeylanica. Nat Prod Res. 2024;38(10):1719\u20131726.","journal-title":"Nat Prod Res"},{"issue":"10","key":"e_1_3_3_139_1","doi-asserted-by":"crossref","first-page":"4325","DOI":"10.7150\/thno.105782","article-title":"A natural small molecule isoginkgetin alleviates hypercholesterolemia and atherosclerosis by targeting ACLY","volume":"15","author":"Zhang Z","year":"2025","unstructured":"Zhang Z, Chen M, Xu Y, Wang Z, Liu Z, He C, Zhang F, Feng X, Ni X, Chen Y, et al. A natural small molecule isoginkgetin alleviates hypercholesterolemia and atherosclerosis by targeting ACLY. Theranostics. 2025;15(10):4325\u20134344.","journal-title":"Theranostics"},{"key":"e_1_3_3_140_1","doi-asserted-by":"crossref","first-page":"106874","DOI":"10.1016\/j.fitote.2025.106874","article-title":"Identification of a novel ACLY inhibitor proanthocyanidin B2 from grape seeds with lipid-lowering effect in vitro","volume":"187","author":"Wang Y","year":"2025","unstructured":"Wang Y, Wang P, Xu F, Zhou H, Xie X, Hou T, Luo F, Sun Y, Liu Y, Wang J, et al. Identification of a novel ACLY inhibitor proanthocyanidin B2 from grape seeds with lipid-lowering effect in vitro. Fitoterapia. 2025;187:106874.","journal-title":"Fitoterapia"},{"issue":"9","key":"e_1_3_3_141_1","first-page":"1122","article-title":"Structurally diverse terpenoids from Pseudotsuga brevifolia and their inhibitory effects against ACL and ACC1 enzymes","volume":"23","author":"Zhou P","year":"2025","unstructured":"Zhou P, Zhao Z, Zang Y, Xiong J, Choo Y-M, Li J, Hu J. Structurally diverse terpenoids from Pseudotsuga brevifolia and their inhibitory effects against ACL and ACC1 enzymes. Chin J Nat Med. 2025;23(9):1122\u20131132.","journal-title":"Chin J Nat Med"}],"container-title":["Journal of Enzyme Inhibition and Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14756366.2026.2744392","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/14756366.2026.2744392","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14756366.2026.2744392","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T02:07:23Z","timestamp":1792030043000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14756366.2026.2744392"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,14]]},"references-count":140,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12,31]]}},"alternative-id":["10.1080\/14756366.2026.2744392"],"URL":"https:\/\/doi.org\/10.1080\/14756366.2026.2744392","relation":{},"ISSN":["1475-6366","1475-6374"],"issn-type":[{"value":"1475-6366","type":"print"},{"value":"1475-6374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,14]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ienz20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ienz20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-07-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-17","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-30","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-10-14","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2744392"}}